Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
RARG对胃癌细胞活力和迁移能力的影响
RAROC在中国商业银行实务中的计量及其系统构建
RAROC框架下的证券投资基金市场风险实证分析
RAROC在保险企业资本配置中的应用
RAROC模型在银行风险管理中的应用
RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques
RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation
RARRES3 suppressed metastasis through suppression of MTDH to regulate epithelial-mesenchymal transition in colorectal cancer
RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study
RARS: a Resource-Aware Replica Selection and co-allocation scheme for mobile grid
RARS2 mutations in a sibship with infantile spasms
RARS2 mutations cause early onset epileptic encephalopathy without ponto-cerebellar hypoplasia
RARS with fibrosis and del(20q) transformed into ALL
RARTF: Database and tools for complete sets of Arabidopsis transcription factors
RARZ: Ring-Zone Based Routing Protocol for Wireless Sensor Networks
RARtool: A MATLAB Software Package for Designing Response-Adaptive Randomized Clinical Trials with Time-to-Event Outcomes
RAS Technology of the SX-9
RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population
RAS signalling in the colorectum in health and disease
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis
RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia
RAS Mutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers
RAS and ROS in Rhabdomyosarcoma
RAS testing of colorectal carcinoma-a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group
RAS Mutations in Thyroid Cancer
RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage
RAS mutations and cetuximab in locally advanced rectal cancer: Results of the EXPERT-C trial
RAS Mutations in Colorectal Cancer
RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures
RAS in FGF23: Another Piece in the Puzzle
RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression
RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers
RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma
RAS DOES NOT CONTRIBUTE TO THE FACILITATION OF HIPPOCAMPAL SYNAPTIC PLASTICITY ENABLED BY ENVIRONMENTAL ENRICHMENT
RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAF(V600E) Mutation-Negative Nodules?
RAS Mutations Beyond KRAS Exon 2: A Review and Discussion of Clinical Trial Data
RAS isoforms and mutations in cancer at a glance
RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer
RAS one-equation turbulence model with non-singular eddy-viscosity coefficient
RAS testing in metastatic colorectal cancer: advances in Europe
RAS mutation acts as a biomarker during colorectal cancer course in forming the lung metastasis
RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
RAS Pathways in Prostate Cancer - Mediators of Hormone Resistance?
RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
RAS oncogenes: weaving a tumorigenic web
RAS And PKA pathways in cancer: new insight from transcriptional analysis
RAS and microbial maturation as tools for K-selection of microbial communities improve survival in cod larvae
RAS Blockade for Every Diabetic Patient: Pro and Con
RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
RAS blockade, hyperkalemia and AKI-look and you will find
RAS signaling promotes resistance to JAK inhibitors by suppressing BAD- mediated apoptosis
RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
RAS Mutations Predict Radiologic and Pathologic Response in Patients Treated with Chemotherapy Before Resection of Colorectal Liver Metastases
RAS and Hedgehog - partners in crime
RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia
RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact